Current through Register Vol. XLI, No. 38, September 20, 2024
28.1. The program shall complete a physical
and biopsychosocial evaluation, which shall be used to develop the long-term
individualized treatment plan of care. The physical and biopsychosocial
evaluations shall integrate information obtained in all treatment of the
patient at the MAT program.
28.2.
The physical and biopsychosocial evaluations shall include information obtained
from:
28.2.a. The patient;
28.2.b. Family members, when applicable and
permitted;
28.2.c. Friends and
peers, when appropriate and permitted; and
28.2.d. Other appropriate and permitted
collateral sources.
28.3.
The physical assessment shall include information regarding the following:
28.3.a. A physical assessment;
28.3.b. An update to any immediate relevant
history, including, but not limited to, the determination of chronic or acute
medical conditions such as diabetes, renal disease, hepatitis, sickle cell
anemia, tuberculosis, HIV exposure, sexually transmitted disease, chronic
cardiopulmonary disease and pregnancy;
28.3.c. A determination of currently
prescribed medications or utilized over-the-counter substances;
28.3.d. Medications prescribed that are not a
target of treatment or concern;
28.3.e. Medication allergies or adverse
reactions to medications;
28.3.f. A
determination and evaluation of the patient's use of other substances of abuse
and alcohol;
28.3.g. A drug
screen;
28.3.h. An inquiry to and
report from the Controlled Substances Monitoring Program database;
28.3.i. An inquiry whether the patient is
enrolled in any other MAT program; and
28.3.j. Screen for communicable diseases and
address them as needed with treatment or referral and evaluate patient's level
of physical, psychological and social functioning or impairment.
28.4. The biopsychosocial
assessment shall include information about the patient's:
28.4.a. Personal strengths;
28.4.b. Individualized needs;
28.4.c. Abilities or interests;
28.4.d. Presenting problems, including a
thorough analysis of the individual's substance use disorders such as, licit
and illicit drugs used, including alcohol; amounts of drugs or alcohol used;
frequency of use; duration of use; symptoms of physical addiction; history of
treatment for substance use disorder; adverse consequences of use;
inappropriate use of prescribed substances; and urgent needs, including suicide
risk;
28.4.e. Previous behavioral
health services, including diagnostic information; treatment information;
efficacy of current or previously used medication; physical health history and
current status; diagnoses; mental status and current level of
functioning;
28.4.f. Pertinent
current and historical life situation information, including the patient's age;
gender; employment history; involvement in legal proceedings; family history;
history of abuse or neglect; and relationships, including natural
supports;
28.4.g. Assessment of the
individual's access to social supports, family, friends, employment, housing,
finances and whether any legal problems exist;
28.4.h. Use of alcohol and tobacco;
28.4.i. Need for, and availability of, social
supports;
28.4.j. Risk-taking
behaviors;
28.4.k. Level of
educational functioning;
28.4.l.
Adjustment to disabilities or disorders; and
28.4.m. Motivation for treatment.
28.5. The patient's primary
counselor shall review the biopsychosocial assessment and prepare a concise,
interpretive multidisciplinary summary that:
28.5.a. Is based on the assessment
data;
28.5.b. Describes and
evaluates the level and severity of the individual's substance use disorder
behaviors;
28.5.c. Is used in the
development of the individualized treatment plan of care; and
28.5.d. Identifies any co-occurring
disabilities or disorders that should be addressed in the development of the
individualized treatment plan of care.